martes, 30 de junio de 2015

EL BIRUNI: CIENCIAS MÉDICAS NEWS ▲ DIRECTORIO DE DOCUMENTOS EDITADOS EN JUNIO de 2015 [*] ► Contenidos Copyright by Cerasale, Víctor Norberto; 2008 a 2015. SALTA / ARGENTINA.

EL BIRUNI: CIENCIAS MÉDICAS NEWS  DIRECTORIO DE DOCUMENTOS EDITADOS EN JUNIO de 2015 [*]  Contenidos Copyright by Cerasale, Víctor Norberto; 2008 a 2015. SALTA / ARGENTINA.

Contenidos Copyright by Cerasale, Víctor Norberto. Salta, Argentina. 2008 a 2015.
MARTES 30 de  JUNIO de 2015

readers ► ¡13.331.296and adding 

visitas registradas por Google+ ► 484,0 MILLONES!!
SABIDURÍA implica HUMILDAD





CIENCIAS MÉDICAS NEWS
CIENCIAS MÉDICAS APLICADAS
RESEARCH & CLINICAL DEVELOPMENT
SABIDURÍA implica HUMILDAD
Abū'r-Raihān Muhammad ibn Ahmad al-Bīrūnī

EL BIRUNI: DIRECTORIO DE DOCUMENTOS EDITADOS EN JUNIO de 2015[*]
Copyright by Cerasale, Víctor Norberto | Propiedad Intelectual con Derechos Reservados


SÉPTIMO AÑO


GRUPO DE BLOGS SALUD EQUITATIVA
► Iniciado en enero de 2009:
▲ CIENCIAS MÉDICAS NEWS
► Iniciado en abril de 2008:
▲ GESTIÓN EN SALUD PÚBLICA
► Iniciado en enero de 2009:
▲ CIENCIAS DE LA HERENCIA

Páginas vistas por países

Gráfico de los países más populares entre los lectores del blog
EntradaPáginas vistas
Estados Unidos
2.528.228
Ucrania
388.834
Alemania
310.044
Francia
247.819
Rusia
131.465
Reino Unido
97.386
Noruega
84.664
Suecia
60.848
Irlanda
57.999
Argentina
45.140





Contador Google ►

LECTORES desde enero 2009 a la fecha5.360.485
LECTORES totales conjuntos (todos los blogs [5]): 13.331.296
TOTAL de Páginas consultadas, copiadas, distribuidas, traducidas, comentadas, etc. desde el inicio de los blogs (3): > 207,9 millones

El Blog se rige por la información Google.
Google registra ► [datos al 30/06/2015]
Páginas vistas en el último mes: 123.196
Páginas totales vistas en el último mes: 319.798
Páginas vistas (historial completo):     5.360.485
Documentos editados durante el mes de JUNIO de 2015: 1.095
Documentos editados acumulados durante 20156.470

Documentos editados desde el inicio del blog: 65.274
Documentos totales editados en los blog´s ► 181.131


ARCHIVO DEL BLOG

NUESTRA SEÑORA DE LA MEDALLA MILAGROSA

NUESTRA SEÑORA DE LA MEDALLA MILAGROSA
guía y luz a lo largo de mi vida

Webinar Series: Health Insurance

Webinar Series: Health Insurance



Main Header



Do you work with people who have questions about getting and using health insurance? 

We may have the answers they need! Check out these FREE webinars covering a variety of topics around the Affordable Care Act (ACA). To RSVP, please click on the date you wish to attend.
New Graduates and Health Care: Learn Your Options!
Know a recent college grad? Do they have health insurance? If not, they could be just one car accident or sports injury away from an expensive health care bill and potential bankruptcy. Help new graduates learn about their coverage options with this webinar.
Got Coverage? Next Steps in Using Your Health Insurance
Many people have health insurance but may not know how to use it. This webinar will help the people in your community understand their benefits and connect to primary care and the preventive services that are right for them, so they can live long and healthy lives.
Special Enrollment Periods and Resources for the Uninsured
Know someone who recently turned 26, had a baby, lost their health insurance, or graduated from college? If so, they can enroll in the Health Insurance Marketplace during special enrollment periods. Join this webinar to learn more about special enrollment periods and how to sign up.
Best Practices in ACA Outreach and Enrollment
Learn from faith leaders who have conducted successful outreach and enrollment campaigns before and during open enrollment.

Guidances (Drugs) > Product-Specific Recommendations for Generic Drug Development

Guidances (Drugs) > Product-Specific Recommendations for Generic Drug Development

FDA Logo



FDA has published 48 product-specific recommendations (44 new and 4 revised) describing the Agency’s current thinking and expectations on how to develop generic drug products therapeutically equivalent to specific reference-listed drugs.

FDA is always seeking feedback and considers all comments to the docket before it begins work on the final version of the BE guidance.

For more information and to view the recommendations, visit http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm075207.htm